Can simple and low-cost motor function assessments help in the diagnostic suspicion of Duchenne muscular dystrophy?
- PMID: 31009620
- PMCID: PMC9432257
- DOI: 10.1016/j.jped.2019.02.003
Can simple and low-cost motor function assessments help in the diagnostic suspicion of Duchenne muscular dystrophy?
Abstract
Objective: Duchenne muscular dystrophy, an X-linked genetic disease, leads to progressive muscle weakness mainly in the lower limbs. Motor function tests help to monitor disease progression. Can low-cost, simple assessments help in the diagnostic suspicion of Duchenne muscular dystrophy? The authors aim to define the sensitivity of time to rise from the floor, time to walk 10meters, and time to run 10meters, evaluating them as eventual diagnostic screening tools.
Methods: This is an analytical, observational, retrospective (1998-2015), and prospective study (2015-2018). Cases were recruited from the database of the pediatric neurology department and the healthy, from child care consultations, with normal gait development (up to 15 months) and without other comorbidities (neuromuscular, pulmonary, heart diseases) from the same university hospital.
Results: 128 Duchenne muscular dystrophy patients and 344 healthy children were analyzed, equally distributed in age groups. In Duchenne muscular dystrophy, there is a progressive increase in the means of the times to perform the motor tests according to the age group, which accelerates very abruptly after 7 years of age. Healthy children acquire maximum motor capacity at 6 years and stabilize their times. The time to rise showed a p-value <0.05 and a strong association (effect size [ES] >0.8) in all age groups (except at 12 years), with time to walk 10 meters from 9 years, and with time to run 10 meters , from 5 years. The 100% sensitivity points were defined as follows: time to rise, at 2s; time to walk 10 meters, 5s; time to run 10 meters, 4s.
Conclusions: Time to rise is a useful and simple tool in the screening of neuromuscular disorders such as Duchenne muscular dystrophy, a previously incurable disease with new perspectives for treatment.
Objetivo: A distrofia muscular de Duchenne, doença genética ligada ao X, determina fraqueza muscular progressiva principalmente em membros inferiores. Os testes de função motora ajudam a monitorar a progressão da doença. Avaliações simples de baixo custo podem ajudar na suspeita diagnóstica da distrofia muscular de Duchenne? Objetivamos definir a sensibilidade do tempo levantar, tempo andar 10 metros e tempo correr 10 metros, avaliando-os como eventuais ferramentas de triagem diagnóstica.
Métodos: Estudo analítico, observacional, retrospectivo (1998 até 2015) e prospectivo (2015 até 2018). Os casos foram recrutados do banco de dados do serviço de neurologia infantil e os saudáveis, de consultas de puericultura, com desenvolvimento de marcha normal (até os 15 meses) e sem outras comorbidades (neuromusculares, pneumopatias, cardiopatias), do mesmo hospital universitário.
Resultados: Foram analisados 128 pacientes com distrofia muscular de Duchenne e 344 saudáveis, distribuídos igualmente em faixas etárias. Na distrofia muscular de Duchenne ocorre aumento progressivo das médias dos tempos para realizar as provas motoras, de forma acentuada a partir dos 7 anos. Os saudáveis estabilizam os tempos a partir dos 6 anos, adquirindo capacidade motora máxima. O tempo de levantar apresentou p-valor <0,05 e forte associação (TE >0,8) em todas as faixas etárias (exceto aos 12 anos), tempo de andar 10 metros a partir de 9 anos e o tempo de correr 10 metros, dos 5 anos. Os pontos de 100% sensibilidade foram definidos: tempo de levantar aos 2 segundos; tempo de andar, 5 segundos e tempo de correr 10 metros, 4 segundos.
Conclusões: O tempo de levantar é útil e simples na triagem de doenças neuromusculares como a distrofia muscular de Duchenne, doença antes incurável com novas perspectivas de tratamento.
Keywords: Atividade motora; Caminhada; Child development; Child development deviations; Desenvolvimento infantil; Desvios do desenvolvimento infantil; Developmental delay disorders; Habilidade motora; Motor activity; Motor skills; Transtornos de atraso do desenvolvimento; Walking.
Copyright © 2019 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda. All rights reserved.
Figures



Similar articles
-
Steroid treatment and the development of scoliosis in males with duchenne muscular dystrophy.J Bone Joint Surg Am. 2004 Mar;86(3):519-24. doi: 10.2106/00004623-200403000-00009. J Bone Joint Surg Am. 2004. PMID: 14996877 Clinical Trial.
-
Walking and weakness in children: a narrative review of gait and functional ambulation in paediatric neuromuscular disease.J Foot Ankle Res. 2020 Mar 2;13(1):10. doi: 10.1186/s13047-020-0378-2. J Foot Ankle Res. 2020. PMID: 32122377 Free PMC article. Review.
-
Progression of muscular co-activation and gait variability in children with Duchenne muscular dystrophy: A 2-year follow-up study.Clin Biomech (Bristol). 2020 Aug;78:105101. doi: 10.1016/j.clinbiomech.2020.105101. Epub 2020 Jul 3. Clin Biomech (Bristol). 2020. PMID: 32652381
-
Natural History of Steroid-Treated Young Boys With Duchenne Muscular Dystrophy Using the NSAA, 100m, and Timed Functional Tests.Pediatr Neurol. 2020 Dec;113:15-20. doi: 10.1016/j.pediatrneurol.2020.08.013. Epub 2020 Aug 27. Pediatr Neurol. 2020. PMID: 32979653
-
[Pediatric pneumological aspects in the care of children with neuromuscular diseases with focus on Duchenne muscular dystrophy].Klin Padiatr. 2025 Mar;237(2):59-65. doi: 10.1055/a-2464-6210. Epub 2024 Dec 10. Klin Padiatr. 2025. PMID: 39657768 Review. German.
Cited by
-
Detecting early signs in Duchenne muscular dystrophy: comprehensive review and diagnostic implications.Front Pediatr. 2023 Nov 10;11:1276144. doi: 10.3389/fped.2023.1276144. eCollection 2023. Front Pediatr. 2023. PMID: 38027286 Free PMC article. Review.
References
-
- Emery A.E. Duchenne muscular dystrophy – Meryon's disease. Neuromuscul Disord. 1993;3:263–266. - PubMed
-
- Emery A.E. Population frequencies of inherited neuromuscular diseases – a world survey. Neuromuscul Disord. 1991;1:19–29. - PubMed
-
- Hoffman E.P., Brown R.H., Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987;51:919–928. - PubMed
-
- Araújo A.P., de Deco M.C., Klôh B.d.S., da Costa M.R., de Góis F.V., Guimarães A.F. Diagnosis delay of Duchenne muscular dystrophy. Rev Bras Saúde Matern Infant. 2004;4:179–183.
-
- Reed U.C. Neuromuscular disorders. J Pediatr (Rio J) 2002;78:S89–S103. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources